Validation of novel and minimally invasive urine and serum biomarkers of kidney diseases in domestic animals.
Determination of the utility of novel biomarkers as indicators of glomerular and tubulointerstitial damage, as markers of specific types of kidney diseases in domestic animals (particularly immune complex-mediated glomerulonephritis in dogs), and as markers of disease progression and patient prognosis.